155 related articles for article (PubMed ID: 21105049)
1. Germline polymorphisms in genes involved in the CD44 signaling pathway are associated with clinical outcome in localized gastric adenocarcinoma.
Winder T; Ning Y; Yang D; Zhang W; Power DG; Bohanes P; Gerger A; Wilson PM; Lurje G; Tang LH; Shah M; Lenz HJ
Int J Cancer; 2011 Sep; 129(5):1096-104. PubMed ID: 21105049
[TBL] [Abstract][Full Text] [Related]
2. Association of Two CD44 Polymorphisms with Clinical Outcomes of Gastric Cancer Patients.
Bitaraf SM; Mahmoudian RA; Abbaszadegan M; Mohseni Meybodi A; Taghehchian N; Mansouri A; Forghanifard MM; Memar B; Gholamin M
Asian Pac J Cancer Prev; 2018 May; 19(5):1313-1318. PubMed ID: 29802692
[TBL] [Abstract][Full Text] [Related]
3. An individual coding polymorphism and the haplotype of the SPARC gene predict gastric cancer recurrence.
Winder T; Wilson PM; Yang D; Zhang W; Ning Y; Power DG; Bohanes P; Gerger A; Tang LH; Shah M; Lenz HJ
Pharmacogenomics J; 2013 Aug; 13(4):342-8. PubMed ID: 22491017
[TBL] [Abstract][Full Text] [Related]
4. Genetic variations in angiogenesis pathway genes associated with clinical outcome in localized gastric adenocarcinoma.
Lurje G; Husain H; Power DG; Yang D; Groshen S; Pohl A; Zhang W; Ning Y; Manegold PC; El-Khoueiry A; Iqbal S; Tang LH; Shah MA; Lenz HJ
Ann Oncol; 2010 Jan; 21(1):78-86. PubMed ID: 19622587
[TBL] [Abstract][Full Text] [Related]
5. CD44 Genotypes Are Associated with Susceptibility and Tumor Characteristics in Colorectal Cancer Patients.
Márquez-González RM; Saucedo-Sariñana AM; Barros-Núñez P; Gallegos-Arreola MP; Pineda-Razo TD; Marin-Contreras ME; Flores-Martínez SE; Sánchez-Corona J; Rosales-Reynoso MA
Tohoku J Exp Med; 2020 Feb; 250(2):109-119. PubMed ID: 32115493
[TBL] [Abstract][Full Text] [Related]
6. Cancer Stem Cell Gene Variants in CD44 Predict Outcome in Stage II and Stage III Colon Cancer Patients.
Stotz M; Herzog SA; Pichler M; Smolle M; Riedl J; Rossmann C; Bezan A; Stöger H; Renner W; Berghold A; Gerger A
Anticancer Res; 2017 Apr; 37(4):2011-2018. PubMed ID: 28373475
[TBL] [Abstract][Full Text] [Related]
7. CD44 single nucleotide polymorphism and isoform switching may predict gastric cancer recurrence.
Suenaga M; Yamada S; Fuchs BC; Fujii T; Kanda M; Tanaka C; Kobayashi D; Fujiwara M; Tanabe KK; Kodera Y
J Surg Oncol; 2015 Nov; 112(6):622-8. PubMed ID: 26416034
[TBL] [Abstract][Full Text] [Related]
8. GRP78 promoter polymorphism rs391957 as potential predictor for clinical outcome in gastric and colorectal cancer patients.
Winder T; Bohanes P; Zhang W; Yang D; Power DG; Ning Y; Gerger A; Wilson PM; Tang LH; Shah M; Lee AS; Lenz HJ
Ann Oncol; 2011 Nov; 22(11):2431-2439. PubMed ID: 21382870
[TBL] [Abstract][Full Text] [Related]
9. Increased CD44 Expression and MEK Activity Predict Worse Prognosis in Gastric Adenocarcinoma Patients Undergoing Gastrectomy.
Lin JX; Yoon C; Li P; Yu Q; Qiu SL; Zheng CH; Yoon SS; Huang CM
J Gastrointest Surg; 2021 May; 25(5):1147-1155. PubMed ID: 32410176
[TBL] [Abstract][Full Text] [Related]
10. LETM1 is a potential biomarker that predicts poor prognosis in gastric adenocarcinoma.
Li H; Piao L; Xu D; Xuan Y
Exp Mol Pathol; 2020 Feb; 112():104333. PubMed ID: 31705880
[TBL] [Abstract][Full Text] [Related]
11. Genetic association of osteopontin (OPN) and its receptor CD44 genes with susceptibility to Chinese gastric cancer patients.
Qiu Y; Hu Y; Zhang ZY; Ye L; Xu FH; Schneider ME; Ma XL; Du YX; Zuo XB; Zhou FS; Chen G; Xie XS; Zhang Y; Xia HZ; Wu JF; Du WD
J Cancer Res Clin Oncol; 2014 Dec; 140(12):2143-56. PubMed ID: 25009318
[TBL] [Abstract][Full Text] [Related]
12. DNA repair gene and MTHFR gene polymorphisms as prognostic markers in locally advanced adenocarcinoma of the esophagus or stomach treated with cisplatin and 5-fluorouracil-based neoadjuvant chemotherapy.
Ott K; Rachakonda PS; Panzram B; Keller G; Lordick F; Becker K; Langer R; Buechler M; Hemminki K; Kumar R
Ann Surg Oncol; 2011 Sep; 18(9):2688-98. PubMed ID: 21347786
[TBL] [Abstract][Full Text] [Related]
13. Common Variants in Osteopontin and
Gałecki S; Gdowicz-Kłosok A; Deja R; Masłyk B; Giglok M; Suwiński R; Butkiewicz D
Cells; 2023 Nov; 12(23):. PubMed ID: 38067149
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of Cyclin D1 and CD44 Expression in Gastric Adenocarcinoma.
Ibrahim HM; AbdElbary AM; Mohamed SY; Elwan A; Abdelhamid MI; Ibrahim A
J Gastrointest Cancer; 2019 Sep; 50(3):370-379. PubMed ID: 29497929
[TBL] [Abstract][Full Text] [Related]
15. CD44/CD24 expression in recurrent gastric cancer: a retrospective analysis.
Yong CS; Ou Yang CM; Chou YH; Liao CS; Lee CW; Lee CC
BMC Gastroenterol; 2012 Jul; 12():95. PubMed ID: 22839505
[TBL] [Abstract][Full Text] [Related]
16. Genetic variations in angiogenesis pathway genes predict tumor recurrence in localized adenocarcinoma of the esophagus.
Lurje G; Leers JM; Pohl A; Oezcelik A; Zhang W; Ayazi S; Winder T; Ning Y; Yang D; Klipfel NE; Chandrasoma P; Hagen JA; DeMeester SR; DeMeester TR; Lenz HJ
Ann Surg; 2010 May; 251(5):857-64. PubMed ID: 20101173
[TBL] [Abstract][Full Text] [Related]
17. Expression of Cancer Stem Cell Marker CD44 and Its Polymorphisms in Patients with Chronic Gastritis, Precancerous Gastric Lesion, and Gastric Cancer: A Cross-Sectional Multicenter Study in Thailand.
Tongtawee T; Wattanawongdon W; Simawaranon T; Kaewpitoon S; Kaengpenkae S; Jintabanditwong N; Tangjanyatham P; Ratchapol W; Kangwantas K; Dechsukhum C; Leeanansaksiri W; Kaewpitoon N; Matrakool L; Panpimanmas S
Biomed Res Int; 2017; 2017():4384823. PubMed ID: 29445738
[TBL] [Abstract][Full Text] [Related]
18. The fibroblast growth factor receptor-4 Arg388 allele is associated with gastric cancer progression.
Ye Y; Shi Y; Zhou Y; Du C; Wang C; Zhan H; Zheng B; Cao X; Sun MH; Fu H
Ann Surg Oncol; 2010 Dec; 17(12):3354-61. PubMed ID: 20844967
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
Guo J; Zu G; Zhou T; Xing J; Wang Z
Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor receptor 2 gene polymorphisms as predictors for tumor recurrence and overall survival in non-small-cell lung cancer.
Uzunoglu FG; Kaufmann C; Wikman H; Güngör C; Bohn BA; Nentwich MF; Reeh M; Pantel K; Bockhorn M; Kutup A; Mann O; Izbicki JR; Vashist YK
Ann Surg Oncol; 2012 Jul; 19(7):2159-68. PubMed ID: 22395975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
